TRAF2 and atherosclerosis: In addition, selective TRAF6 inhibition prevents pro-inflammatory cytokine secretion of macrophages as well as immune suppressive side effects by preserving CD40-TRAF2/3/5 (anti-inflammatory) signaling and reducing thereby established atherosclerosis.